Skip to Main content Skip to Navigation

PPARgamma-independente activity of PPARgamma ligands: a new perspective for the treatment of breast cancers ?

Abstract : One of the main goals of the anti-cancer research is to develop new therapeutic option for resistant tumor. In this context, the recent discovery of thiazolidinedione devoid of PPARgamma activity with a strong anti-cancer effect opens new perspectives. In a previous study, the laboratory showed that an inactive derivative of PPARgamma, the delta2-TGZ, induce a proteasome-dependent degradation of estrogen receptor alpha in PPARgamma-independent way. Thus, during my thesis we aimed 1) to participate in the study of new compounds less toxic and more effective to inhibit the proliferation of mammary cancer cells, 2) to better understand PPARgamma-independent mechanisms involved in the anti-cancer effect of the TZD. In the present work, we characterise new compounds more effective than delta2-TGZ to inhibit the proliferation of the breast cancer cells MCF-7 and MDA-MB-231 and are less toxic on primary culture of human hepatocytes. We pursued the study on mechanisms involved in PPARgamma-independent anti-proliferative activity of delta2-TGZ. We showed that delta2-TGZ is able to induce endoplasmic reticulum stress as soon as 3 hours and apoptosis in later times 48 hours of treatment. Nevertheless we could not conclude of the existence of a link between these two pathways. Finally, we studied the effect of the biotinylation of a natural ligand of PPAR?: the 15d-PGJ2. This modification drive to an increased effect of the 15d-PGJ2 on the anti-proliferative effect of breast cancer cells, reticulum endoplasmic stress and death by apoptosis. These effects are partially PPARgamma-dependent for reticulum endoplasmic stress and only PPARgamma-independent for apoptosis. This work highlighted new promising tools of breast cancers treatment
Document type :
Complete list of metadata
Contributor : Thèses Ul Connect in order to contact the contributor
Submitted on : Thursday, March 29, 2018 - 12:48:24 PM
Last modification on : Saturday, October 16, 2021 - 11:14:14 AM


Files produced by the author(s)


  • HAL Id : tel-01750525, version 1


Christelle Colin-Cassin. PPARgamma-independente activity of PPARgamma ligands: a new perspective for the treatment of breast cancers ?. Human health and pathology. Université de Lorraine, 2013. English. ⟨NNT : 2013LORR0232⟩. ⟨tel-01750525⟩



Record views


Files downloads